Aetna Medical Policy Updates – September 2018

Click here to view the Aetna Medical Policy Updates »

September 2018 Aetna Medical Policy Updates:

• Anakinra (Kineret)
• Axicabtagene Ciloleucel (Yescarta)
• Benralizumab (Fasenra)
• Brain Natriuretic Peptide Testing
• Bunionectomy
• Copanlisib (Aliqopa)
• Drug-Eluting Stents
• Dysphagia Therapy
• Fecal Incontinence
• Gemtuzumab Ozogamicin (Mylotarg)
• Gender Reassignment Surgery
• Hammertoe Repair
• Hematopoietic Cell Transplantation for Aplastic Anemia and other Bone Marrow Failure Syndromes
• Huntington’s Disease
• Infliximab
• Inotuzumab Ozogamicin (Besponsa)
• Intraoperative Radiation Therapy (IORT)
• Luxturna (Voretigene Neparvovec-rzyl)
• Lysosomal Storage Disorders Treatments
• Optical Coherence Tomography of the Middle Ear
• Osteoarthritis of the Knee: Selected Treatments
• Prosthetic Limb Vacuum Systems
• Pulmonary Hypertension Treatments and Selected Indications of Prostanoids
• Tisagenlecleucel (Kymriah)
• Tocilizumab (Actemra)
• Tofacitinib (Xeljanz)
• Transperineal Placement of Biodegradeable Material (SpaceOAR) for Prostate Cancer
• Vyxeos (Daunorubicin-Cytarabine) Liposome

Added 9/27/2018;

• Abatacept (Orencia)
• Adalimumab (Humira)
• Adoptive Immunotherapy and Cellular Therapy
• Anakinra (Kineret)
• Autism Spectrum Disorders
• Bone Mass Measurements
• Bortezomib (Velcade)
• Cerebral Perfusion Studies
• Certolizumab Pegol (Cimzia)
• Constraint-Induced Therapy
• Decitabine (Dacogen)
• Diagnosis of Vaginitis
• Electrical Stimulation for Nausea, Vomiting and Motion Sickness (PrimaBella and ReliefBand) and Other Selected Indications
• Enbrel (Etanercept)
• Endovascular Repair of Aortic Aneurysms
• Esophageal and Airway pH Monitoring
• Extracorporeal Shock-Wave Therapy for Musculoskeletal Indications and Soft Tissue Injuries
• Functional Electrical Stimulation and Neuromuscular Electrical Stimulation
• Golimumab (Simponi and Simponi Aria)
• Hereditary Angioedema
• Infliximab – Medical Clinical Policy Bulletins | Aetna
• Ipilimumab (Yervoy)
• Joint Resurfacing
• Near-Infrared (NIR) Spectroscopy
• Nivolumab (Opdivo)
• Osteoarthritis of the Knee: Selected Treatments
• Pamidronate (Aredia)
• Pembrolizumab (Keytruda)
• Photodynamic Therapy for Acne
• Psoriasis and Psoriatic Arthritis: Targeted Immune Modulators
• Radioimmunotherapy for Non-Hodgkin’s Lymphoma: Ibritumomab Tiuxetan (Zevalin) and Tositumomab (Bexxar)
• Rituximab (Rituxan)
• Teriparatide (Forteo)
• Therapeutic Phlebotomy
• Tocilizumab (Actemra)
• Total Ankle Arthroplasty
• Trastuzumab (Herceptin), Ado-Trastuzumab (Kadcyla) and Pertuzumab (Perjeta)
• Unicompartmental, Bicompartmental, and Bi-unicompartmental Knee Arthroplasties
• Ventricular Assist Devices
• Xolair (Omalizumab)

Click here to view the Aetna Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.